Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study - Takeaways - MDSpire

Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study

  • By

  • Ami Inokuchi

  • Haryoon Kim

  • Masatoshi Sakurai

  • Kyoko Masuda

  • Kota Mizuno

  • Yuya Koda

  • Eri Matsuki

  • Yasunori Kogure

  • Shoko Ukita

  • Megumi Maeda

  • Futoshi Oda

  • Yuko Kaneko

  • Yasunori Sato

  • Haruhisa Fukuda

  • Keisuke Kataoka

  • December 2, 2025

  • 0 min

Share

  • 1

    IDD-lymphomas arise in various settings, including autoimmune diseases, and are classified as iatrogenic immunodeficiency-associated lymphoproliferative disorders.

  • 2

    Specific autoimmune diseases are associated with distinct lymphoma subtypes, such as MALT lymphoma linked to Sjögren’s syndrome and Hashimoto thyroiditis.

  • 3

    Treatment for IDD-lymphomas often involves reducing immunosuppression, but many cases require rituximab or cytotoxic therapy for effective disease control.

  • 4

    The cumulative effect of multiple immunosuppressive agents on lymphoma risk in autoimmune diseases remains inadequately studied despite increasing medication use.

  • 5

    The LIFE Study analyzed lymphoma risk across 23 autoimmune diseases, focusing on the impact of immunosuppressive therapies on lymphoma subtype-specific risks.

Original Source(s)

Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study

  • by Ami Inokuchi, Haryoon Kim, Masatoshi Sakurai, Kyoko Masuda, Kota Mizuno, Yuya Koda, Eri Matsuki, Yasunori Kogure, Shoko Ukita, Megumi Maeda, Futoshi Oda, Yuko Kaneko, Yasunori Sato, Haruhisa Fukuda, Keisuke Kataoka

  • December 2, 2025

Related Content

Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study

Strategies for Organ Regeneration Using Cell Therapy

Epstein-Barr virus associated diseases: Immune alterations and targeted approaches